Graphical abstract A new conjugating strategy was developed to construct effective self-adjuvanting protein vaccines through sialoglycoconjugation. The resulting adjuvant-glycoprotein conjugate (TLR7a-S1) induced effective anti-virus humoral and cellular immunity. Unlabelled Image
All Keywords
【저자키워드】 SARS-CoV-2, Subunit vaccine, TLR7 agonist, built-in adjuvant, Protein conjugate,
【저자키워드】 SARS-CoV-2, Subunit vaccine, TLR7 agonist, built-in adjuvant, Protein conjugate,